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Abstract. Clinical processes can be described, inside the Biomedical scope, like 
a systematic guideline to assist practitioner and patient decisions about appro-
priate health care for specific clinical circumstances. In industry, Product Life-
cycle Management (PLM) is the process of managing the entire lifecycle of a 
product from inception, through engineering design and manufacture, to service 
and disposal of manufactured products. Applying the concepts of PLM to Bio-
medical processes we create a synergy between the product’s concept in the in-
dustrial case and the patient into the health care environment. This point of 
view improves the actual clinical processes with a most specific treatment for 
each patient, by modifying the statements to assist the patient according to 
the needs of the patient and his illness. This research proposal tries to shift the 
focus of the eHealth systems onto the patient, adapts the existing and defined 
clinical processes or clinical paths to the patient’s needs, applies Big Data 
principles to bring even more attentions for the patient, and provides an easy to 
use system for the medical staff.   
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1 Introduction 
In the last decade, the health care sector has used clinical guidelines and protocols as 
helpful instruments for decision-making. As defined by the Institute of Medicine, 
clinical guidelines are systematically developed statements to assist practitioner and 
patient decisions about appropriate health care for specific clinical circumstances [1]. 
They describe all the decision points and corresponding actions to be carried out de-
pending on a specific patient’s state or situation. Furthermore, clinical guidelines 
identify the clinical tests to be performed in order to confirm or determine the 
patient’s state. Based on the test results, the guideline determines the treatment alter-
natives. Among the most important potential advantages of documenting and 
using 
clinical guidelines are assessing and improving the quality of care, providing support 
for medical decision-making, controlling health care costs and reducing both practice 
variability and the inappropriate use of resources [1,2]. 
In industry, product lifecycle management (PLM) is the process of managing the 
entire lifecycle of a product from inception, through engineering design and manufac-
ture, to service and disposal of manufactured products [3]. PLM integrates people, 
data, processes and business systems and provides a product information backbone 
for companies and their extended enterprise. 
The inspiration for the burgeoning business process now known as PLM came 
from American Motors Corporation (AMC). The automaker was looking for a way to 
speed up its product development process to compete better against its larger competi-
tors in 1985 [4]. The first part in its quest for faster product development was com-
puter-aided design (CAD) software system that makes engineers more productive [4]. 
The second part in this effort was the new communication system that allowed con-
flicts to be resolved faster, as well as reducing costly engineering changes because all 
drawings and documents were in a central database.  
The main motivation for this research comes from several projects, regarding 
health care and PLM, in which the research group is involved. After analyzing and 
identifying the advantages and disadvantages of each research area, we focus on try-
ing to improve health care systems using the main advantages that PLM paradigm 
brings. Our approach focuses on improving biomedical systems, by merging the main 
principle of clinical processes, or clinical pathways, with the Product Lifecycle Man-
agement paradigm in the industrial case. In this research proposal, we try to improve 
the attention of a patient with a chronicle illness, adapting the base clinical process, 
defined by specialist, for the patient. Biomedical informatics [5-12] incorporates a 
core set of methodologies that are applicable to data, information, and knowledge 
management across the translational medicine continuum, from bench biology to 
clinical care and research to public health [13]. 
The paper is structured as follows: Section 2 describes the PLM methodology as it is 
in the industrial environment. Section 3 explains our proposal to transform the idea of 
PLM to Patient Treatment. Finally, chapter 4 describes our conclusions and future work. 
2 About PLM 
Product Lifecycle Management (PLM) is the business activity of managing, in the 
most effective way, a company’s product all the way across their lifecycle; from the 
very first idea for the product all the way through until it is retired and disposed of 
[14]. As it is shown in Fig 1, the lifecycle of a product, in most cases, is cyclical. 
From the extraction of the raw materials, passing through the manufacturing produc-
tion and delivery, to the final customers; and once the product is useless, PLM covers 
the disposal of the product and its possible reutilization to recycling. 
One of the most important advantages of using PLM is the interconnection of 
every phase in the product lifecycle across the World; being easily for the company to 
handle its products having different factories placed in different countries. Further-
more, all the information is shared, so the knowledge about the product manufactur-
ing does not belong to a concrete sector. 
Fig. 1. PLM Overview 
PLM manages both individual products and the Product Portfolio, the collection of 
all of a company’s products.  
PLM manages products from the beginning of their life, including development, 
through growth and maturity, to the end of life.  
The objective of PLM is to increase product revenues, reduce product-related 
costs, maximize the value of the product portfolio, and maximize the value of current 
and future products for both customers and shareholders [14].  
However, the benefits of operational PLM go far beyond incremental savings, 
yielding greater bottom line savings and top-line revenue growth not only by imple-
menting tools and technologies, but also by making necessary, and often tough, 
changes in processes, practices and methods and gaining control over product life-
cycle and lifecycle processes. The return on investment for PLM is based on a broader 
corporate business value, specifically the greater market share and increased profita-
bility achieved by streamlining the business processes that help deliver innovative, 
winning products with high brand image quickly to market, while being able to make 
informed lifecycle decisions over the complete product portfolio during the lifecycle 
of each individual product.  
The scope of product information being stored, refined, searched, and shared with 
PLM has expanded. PLM is a holistic business concept developed to manage a prod-
uct and its lifecycle including not only items, documents, and BOM’s (Bill Of Mate-
rials), but also analysis results, test specifications, environmental component informa-
tion, quality standards, engineering requirements, change orders, manufacturing pro-
cedures, product performance information, component suppliers, and so forth.  
On the other hand, modern PLM system capabilities include workflow, program 
management, and project control features that standardize, automate, and speed up 
product management operations. Web-based systems enable companies easily to con-
nect their globally dispersed facilities with each other and with outside organizations 
such as suppliers, partners, and even customers. A PLM system is a collaborative 
backbone allowing people throughout extended enterprises to work together more 
effectively.  
Operational efficiencies are improved with PLM because groups all across the value 
chain can work faster through advanced information retrieval, electronic information 
sharing, data reuse, and numerous automated capabilities, with greater information 
traceability and data security. This allows companies to process engineering change 
orders and respond to product support calls more quickly and with less labor. They can 
also work more effectively with suppliers in handling bids and quotes, exchange criti-
cal product information more smoothly with manufacturing facilities, and allow service 
technicians and spare part sales reps to quickly access required engineering data in the 
field [15]. Nowadays, PLM is used in most of industrial sectors, like automotive, naval 
and aeronautical industry, and architecture among many of them. 
3 Patient Oriented Clinical Processes 
Nowadays, all the biomedical systems are based on new technologies and the interac-
tion with the doctors and medical staff, defining processes for different kinds of ill-
ness [16]. This kind of system improves the health systems by making them more 
efficient and easy to use for doctors. However, these systems overlook the most im-
portant factor in an eHealth system, the Patient. The next image shows the three ver-
tex of a triangle of any eHealth system. 
Fig. 2. eHealth System Organization 
As it is shown on Fig. 2, an eHealth system can be represented by three vertex of a 
triangle. The base of the triangle is focused on Medical Staff and the Technologies 
used in the system. The third vertex, called Patient, provides the information for the 
system. Nowadays, all the studied systems are focused on the base of the triangle, and 
are trying to improve the communication between the system and the medical crew or 
the system itself, by doing it in a more efficient way. 
As mentioned before, there are a large number of published guidelines since each 
guideline is focused on a desired health care outcome. Furthermore, guidelines may 
vary from hospital to hospital since they reflect variations in resources, staff and the 
design of the protocol, as well as in the working philosophy of the hospital in question 
[17]. Because of the vast amount of clinical guidelines, several organizations have 
undertaken efforts to publish them (using text formats such as HTML or PDF) in the 
literature and on the Internet to make them more accessible and to enable evidence-
based knowledge to be reused [18, 19]. 
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indicators for specific cases on each clinical process. These indicators could be misin-
terpreted because the proper patient may indicate a wrong value for its pain. For ex-
ample, we could use a one to five scale to measure patient’s pain, if the patient is 
frightened about his illness, could indicate that its pain is five. Another factor is the 
patient thinks that the most painful is his state will be attended faster, so he will al-
ways say that his pain is the maximum value. To avoid this false value of the indica-
tor, we will use Big Data principles to analyze the indicators of one patient according 
all patients with the same issue. Also it is very important to define the correct indica-
tors and algorithms to avoid mistakes during the patient analysis, providing the best 
process for each patient. 
Due to the high amount of data regarding clinical pathways, for our further re-
search we will focus on three main illness and its treatments; Endometriosis, AIDS 
and Malformations of spinal cord. Thereby we could reduce the scope of this research 
project focusing into three concrete cases. 
As for the future work for this research project, we will start analyzing the State-
Of-the-Art technologies in this domain by conducting a Systematic Literature Review 
[21, 22], and based on the review result, we will try to improve the Biomedical Sys-
tem by applying the proposed method as mentioned previously. 
Acknowledgements. This research project has been partially funded by MeGUS 
Project (TIN2013-46928-C3-3-R) and DExOFlex-BP Project (TIN2014-52382-R) of 
The Ministry of Economy and Competitiveness, Spain. We would like to thank Fujit-
su Laboratory of Europe by the support to this research. 
References 
1. Field, M.J., Lohr, K.N. (eds.): Guidelines for Clinical Practice: From Development to Use.
National Academies Press (1992)
2. Papadopoulos, C.: The development of Canadian clinical practice guidelines: a literature
review and synthesis of findings: Discussion paper prepared for the CCA/CFCRB Task
Force on Chiropractic Clinical Practice Guidelines June 15 2002. The Journal of the Cana-
dian Chiropractic Association 47(1), 39 (2003)
3. Kurkin, O., Januska, M.: Product Life Cycl in Digital factory. In: 15th International-
Business- Information-Management-Association Knowledge Management and Innovation:
A Business Competitive Edge Perspective, vol. 1–3, Cairo, Egypt, November 06, 2007,
ISBN: 978-0-9821489-4-5, pp. 1881–1886 (2010)
4. http://web.archive.org/web/20090213042744/,
http://www.coe.org/coldfusion/newsnet/may03/technology.cfm.
(last accessed: January 2015)
5. Cimino, J.J., Shortliffe, E.H.: Biomedical Informatics: Computer Applications in Health
Care and Biomedicine (Health Informatics). Springer-Verlag New York, Inc. (2006)
6. Greenes, R.A., Shortliffe, E.H.: Commentary: Informatics in biomedicine and health care.
Academic Medicine 84(7), 818–820 (2009)
7. Bernstam, E.V., Hersh, W.R., Johnson, S.B., Chute, C.G., Nguyen, H., Sim, I., Becich,
M.J.: Synergies and distinctions between computational disciplines in biomedical research:
perspective from the Clinical and Translational Science Award programs. Academic Med-
icine: Journal of the Association of American Medical Colleges 84(7), 964
8. Collen, M.F.: The origins of informatics. Journal of the American Medical Informatics
Association 1(2), 91–107 (1994)
9. Collen, M.F.: Fifty years in medical informatics. Yearb. Med. Inform., 174–179 (2006)
10. Haux, R.: Individualization, globalization and health–about sustainable information tech-
nologies and the aim of medical informatics. International Journal of Medical Informat-
ics 75(12), 795–808 (2006)
11. Altman, R.B., Balling, R., Brinkley, J.F., Coiera, E., Consorti, F., Dhansay, M.A., Wieder-
hold, G.: Commentaries on “Informatics and medicine: from molecules to populations”.
Methods of Information in Medicine 47(4), 296 (2008)
12. Embi, P.J., Kaufman, S.E., Payne, P.R.: Biomedical Informatics and Outcomes Research
Enabling Knowledge-Driven Health Care. Circulation 120(23), 2393–2399 (2009)
13. Sarkar, I.N.: Biomedical informatics and translational medicine. J. Transl. Med. 8(1), 22
(2010)
14. Stark, J.: Product lifecycle management, pp. 1–16. Springer, London (2011)
15. Saaksvuori, A., Immonen, A.: Product lifecycle management, p. 22. Springer, Berlin
(2005)
16. Thorwarth, M., Arisha, A.: A simulation-based decision support system to model complex
demand driven healthcare facilities. In: Proceedings of the Winter Simulation Conference
(WSC), pp. 1–12. IEEE (December 2012)
17. Pérez, B., Porres, I.: Authoring and verification of clinical guidelines: A model driven ap-
proach. Journal of Biomedical Informatics 43(4), 520–536 (2010)
18. Agency for Healthcare Research and Quality, National guideline clearinghouse, guidelines
for the prevention of intravascular catheter-related infections,
http://www.guideline.gov (last accessed: January 2015)
19. SEIMC Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica [On-line],
Documentos científicos, http://www.seimc.org/documentos/ (last accessed:
January 2015)
20. Berman, J.J.: Principles of big data: preparing, sharing, and analyzing complex informa-
tion. Newnes (2013)
21. Petticrew, M., Roberts, H.: Systematic reviews in the social sciences: A practical guide.
John Wiley & Sons (2008)
22. Domínguez-Mayo, F.J., Escalona, M.J., Mejías, M., Ross, M., Staples, G.: Towards a Ho-
mogeneous Characterization of the Model-Driven Web Development Methodologies.
Journal of Web Engineering 13(1-2), 129–159 (2014)
